rethinkPeptides Search
Menu
Research citation

Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study.

Diabetes care, 48(8), 1386-1394

Citation

Morales, Daniel R; Bu, Fan; Viernes, Benjamin; DuVall, Scott L; Matheny, Michael E; Simon, Katherine R; Falconer, Thomas; Richter, Lauren R; Ostropolets, Anna; Lau, Wallis C Y; Man, Kenneth K C; Chattopadhyay, Shounak; Mathioudakis, Nestoras; Minty, Evan; Nishimura, Akihiko; Sun, Feng; Yin, Can; Seager, Sarah L; Chai, Yi; Zhou, Jin J; Lu, Yuan; Reyes, Carlen; Pistillo, Andrea; Duarte-Salles, Talita; Blacketer, Clair; Schuemie, Martijn J; Ryan, Patrick B; Krumholz, Harlan M; Hripcsak, George; Khera, Rohan; Suchard, Marc A. (2025). Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study.. Diabetes care, 48(8), 1386-1394. https://doi.org/10.2337/dc25-0154